Table 1.
Study | Location | Years | No. subjects | B. microti seroprevalence | B. microti PCR positive |
---|---|---|---|---|---|
Popovsky et al.[7] | MA | 1988 | 779 | 3–5% | N/A |
Leiby et al.[9] | CT | 1999 | 1,745 | 1.4% | 53% (10/19 seropositives) |
Johnson et al.[10] | CT | 2000–2007 | 27,592 | 0.75–1.5% | N/A |
Johnson et al.[11] | CT | 2009 | 1,002 | 2.5% | 0.3% (3/1002) |
Tonnetti et al.[12] | MN | 2010–2011 | 2,150 | 2% | 2.4% (1/42 seropositives) |
O’Brien et al.[13] | Canada | 2013 | 13,993 | 0% | 0% |